Chargement en cours...
α6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson's Disease
Parkinson's disease is a debilitating movement disorder characterized by a generalized dysfunction of the nervous system, with a particularly prominent decline in the nigrostriatal dopaminergic pathway. Although there is currently no cure, drugs targeting the dopaminergic system provide major s...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
The American Society for Pharmacology and Experimental Therapeutics
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3186078/ https://ncbi.nlm.nih.gov/pubmed/21969327 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/pr.110.003269 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|